After the Ministry of Health of the Nation confirmed the first case of the Omicron variant in Argentina, the focus is back on supplying vaccines against the coronavirus.
Argentina still owes receive millions of doses from various providers, which will allow the country to have enough sera to continue with the placement of third doses and reinforcements in the event of the possible advance of new strains.
The Government speeds up the vaccination campaign due to the appearance of the Omicron variant
According to data from the Public Vaccination Monitor, 1,682,150 additional doses and 808,405 reinforcements have already been placed in health personnel and people over 70 years of age. This strategy is key to prepare the population Faced with the possible danger posed by the Omicron variant, which is easily spread.
How many vaccines against the coronavirus the country received so far
Faced with the threat of the Omicron variant, a question arises: Does the country have enough doses to face a possible new wave of coronavirus?
According to estimates of TN, the country has yet to receive 49,235,345 doses, of the contracts signed with AstraZeneca UK Limited; Modern; Sputnik V; Pfizer; COVAX and CanSino.
- AstraZeneca UK Limited/Oxford. Argentina has already received 21,248,500 doses from this laboratory: 1,181,500 vaccines remain to arrive.
- Modern. The contract is for 20 million doses, which will begin to arrive in 2022.
- Sputnik V. So far, 20,371,335 of sera have arrived and have been packaged in the country. An additional 9,628,665 serums remain to be packaged at the Richmond plant.
- Pfizer. 10,654,020 doses arrived from the United States. 9,345,980 vaccines remain by contract.
- COVAX mechanism: 3,616,800 arrived. 5,383,200 remain.
- CanSino: 1,704,000 arrived. 3,696,000 have yet to arrive.
Since the start of the vaccination campaign the country received 94,427,055 doses, from which the million donated to Vietnam, Mozambique and the Organization of Eastern Caribbean States must be subtracted. So far 69,891,521 doses have been applied, of which 36,993,929 belong to first doses and 30,407,037 already have the complete scheme.
That is, beyond the doses that still have to reach the country, the Ministry of Health of the Nation has in stock about 24,535,534.
At this time, the country applies third doses and boosters in people over 70 years of age, health professionals and immunocompromised people (regardless of the vaccine they received) and in people over 50 who have been vaccinated with two doses of Sinopharm.
When this stage of vaccination began, it was done with the aim of protecting the most vulnerable sectors of the Delta variant, but the appearance of the Ómicron forces the authorities to speed up the placement of these serums.
The first case of the Ómicron variant in Argentina
The Ministry of Health confirmed the first case of Omicron on the Argentina. It’s about a traveler 38 years old, resident of the province of saint Louis, who attended a work event in South Africa. As reported by the health ministry, he had returned to the country on November 30. The affected person has the complete vaccination scheme and a history of having suffered Covid-19 in March 2021.
As detailed by the Ministry of Health, the first person affected with Ómicron from Argentina is a “38-year-old person, a resident of the province of San Luis, who attended a work event in South Africa, returning to the country on November 30” . They also warned that said traveler has the complete vaccination scheme and a history of having suffered Covid-19 in March 2021.
Regarding the controls, the sanitary portfolio indicated that the affected party “carried out PCR test prior to travel back to Argentina (where he arrived via the United States) according to the established protocols, with the result negative”, While upon reaching national soil a antigen test at International Airport Ezeiza, also with result negative.
Later, he moved in remís from the airport to his home, in the province of San Luis. Meanwhile, after arriving in San Luis soil, he prepared to comply with the corresponding insulation. Last December 2nd the affected person learned that people he shared with at an event in South Africa were diagnosed as positiveTherefore, despite not having symptoms, she contacted her local health system.
Again, the traveler was subjected to diagnostic tests (Antigen Test and PCR) with a positive result. Following notification to national authorities, samples were sent from San Luis for genomic sequencing in the National Reference Laboratory and for study in the Public Health Laboratory of the province of San Luis.